BioStem Technologies (OTCMKTS:BSEM) Announces Earnings Results

BioStem Technologies (OTCMKTS:BSEMGet Free Report) announced its quarterly earnings data on Monday. The company reported 0.30 earnings per share for the quarter, beating the consensus estimate of 0.12 by 0.18, Yahoo Finance reports. The company had revenue of 74.49 million during the quarter, compared to the consensus estimate of 43.99 million.

BioStem Technologies Trading Up 8.4 %

Shares of BSEM stock traded up 1.05 during mid-day trading on Wednesday, reaching 13.55. The stock had a trading volume of 180,100 shares, compared to its average volume of 26,205. The company has a 50-day moving average price of 8.97. BioStem Technologies has a 52-week low of 1.21 and a 52-week high of 15.50.

BioStem Technologies Company Profile

(Get Free Report)

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.

See Also

Receive News & Ratings for BioStem Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioStem Technologies and related companies with MarketBeat.com's FREE daily email newsletter.